Skip to main content
SpringerLink
Log in

Conflict of interest as seen from a researcher’s perspective

  • Published:
Science and Engineering Ethics Aims and scope Submit manuscript

Abstract

The continuous growth of the pharmaceutical industry is expected to require a considerable output of new drugs, with speedy development and approval processes. This profit-driven expansion of the drug market may broaden the already established erosion of the role of academia in favor of commercial clinical research organizations. Less and less control on the clinical trial design, its conduct and the resulting publication[s] is the likely consequence. Academic medicine and governments should find means to sustain the development of independent clinical research.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Pharma2005: An industrial revolution in R&D. New York, NY: PriceWaterhouseCoopers; 1998. Available at http://www.pwcconsulting.com/us/pwccons.nsf/viewwebpages/PharmaPubSeries Accessibility verified May 2002.

  2. The new era of lifestyle drugs. BusinessWeek May 11, 1998. Available at http://www.businessweek.com/1998/19/topstory.htm. Accessibility verified May 2002.

  3. Garattini S. (1997) Are me-too drugs justified? J Nephrol. 10: 283–94.

    Google Scholar 

  4. Montaner J.S., O’Shaughnessy M.V., Schechter M.T. (2001) Industry-sponsored clinical research: a double-edged sword, Lancet 358: 1893–5.

    Article  Google Scholar 

  5. Rochon P.A., Gurwitz J.H, Simms R.W., et al. (1994) A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis. Arch Intern Med. 154: 157–63.

    Article  Google Scholar 

  6. Margreiter R. (2002) Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study. Lancet 359: 741–6.

    Article  Google Scholar 

  7. Perna A., Gotti E., de Bernardis E., Perico N., Remuzzi G. (1996) A logistic-regression model provides novel guidelines to maximize the anti-acute rejection properties of cyclosporine with a minimum of toxicity. J Am Soc Nephrol. 7: 786–91.

    Google Scholar 

  8. Davidoff F., DeAngelis C.D., Drazen J.M., et al. (2001) Sponsorship, authorship and accountability. Lancet 358: 854–6.

    Article  Google Scholar 

  9. Parving H-H, Lehnert H., Bröchner-Mortensen J., Gomis R., Andersen S., Arner P. (2001) The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 345: 870–78.

    Article  Google Scholar 

  10. Brenner B.M., Cooper M.E., de Zeeuw D., et al. (2001) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345: 861–69.

    Article  Google Scholar 

  11. Lewis E.J., Hunsicker L.G., Clarke W.R., et al. (2001) Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345: 851–60.

    Article  Google Scholar 

  12. Hostetter T.H. (2001) revention of End-Stage Renal Disease Due to Type 2 Diabetes. N Engl J Med 345: 910–12.

    Article  Google Scholar 

  13. Kurtzman N.A. (2001) Drug companies should not have the final say in the design of clinical trials. Am J Kidney Dis 38: 1113–4.

    Google Scholar 

  14. Choudhry N.K., Stelfox H.T., Detsky A.S. (2002) Relationship between authors of clinical practice guidelines and the pharmaceutical industry. JAMA 287: 612–17.

    Article  Google Scholar 

  15. About the 1999 WHO/ISH guidelines for the management of hypertension. Available at http://www.uib.no/isf/letter Accessibility verified May 2002.

  16. Hansson L., Zanchetti A., George Carruthers S., et al. (1998) Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 351: 1755–62.

    Article  Google Scholar 

  17. Quick J. (2001) Maintaining the integrity of the clinical evidence base. Bulletin of the WHO 79: 1093.

    Google Scholar 

  18. Bodenheimer T. (2000) Uneasy alliance. N Engl J Med 342: 1539–44.

    Article  Google Scholar 

  19. Angell M. (2000) Is academic medicine for sale? N Engl J Med 342: 1516.

    Article  Google Scholar 

  20. Retting R.A. (2000) The industrialization of clinical research. Health Affairs 19: 129–46.

    Article  Google Scholar 

  21. Morin K., Rakatanski H., Riddick F.A., et al. (2002) Managing conflict of interest in the conduct of clinical trials. JAMA 287: 78–84.

    Article  Google Scholar 

  22. Schieppati A., Garattini S., Remuzzi G. (2001) Modulating the profit motive to meet needs of the less-developed world. Lancet. 358: 1638–41.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. “Mario Negri” Institute for Pharmacological Research, Negri Bergamo Laboratories, Via Gavazzeni, 11, 24125, Bergamo, Italy

    Arrigo Schieppati MD, Norberto Perico & Giuseppe Remuzzi

  2. Unit of Nephrology and Dialysis, Azienda Ospedaliera — Ospedali Riuniti, Bergamo, Italy

    Arrigo Schieppati MD & Giuseppe Remuzzi

Authors
  1. Arrigo Schieppati MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Norberto Perico
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Giuseppe Remuzzi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Arrigo Schieppati MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schieppati, A., Perico, N. & Remuzzi, G. Conflict of interest as seen from a researcher’s perspective. SCI ENG ETHICS 8, 337–342 (2002). https://doi.org/10.1007/s11948-002-0053-y

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11948-002-0053-y

Keywords

Search

Navigation